Adverum Biotechnologies, Inc. Logo Image

Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc. Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc. has reached its limit for free report views.

Adverum Biotechnologies, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Adverum Biotechnologies, Inc.

51-200 Employees
Based in Menlo Park, California

Adverum is a gene therapy company advancing novel medicines that can offer life-changing benefits to patients living with serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat wet age-related macular degeneration (wAMD) and rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE).

Ticker:
ADVM
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol

Filter by: